Negara: Selandia Baru
Bahasa: Inggris
Sumber: Medsafe (Medicines Safety Authority)
Papaverine hydrochloride 12 mg/mL
Pfizer New Zealand Limited
Papaverine hydrochloride 12 mg/mL
120 mg/10mL
Solution for injection
Active: Papaverine hydrochloride 12 mg/mL Excipient: Water for injection
Ampoule, glass, Type I, clear, one point cut, 5 x 10 mL, 50 mL
Prescription
Prescription
Boehringer Ingelheim Pharma GmbH & Co KG
Package - Contents - Shelf Life: Ampoule, glass, Type I, clear, one point cut, 5 x 10 mL - 50 mL - 36 months from date of manufacture stored at or below 25°C protect from light
1984-03-08
Version: pfdpapai10421 Supercedes : pfdpapai10219 Page 1 of 10 NEW ZEALAND DATA SHEET 1. PRODUCT NAME DBL™ Papaverine Hydrochloride 120 mg/10mL Solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION DBL Papaverine Hydrochloride Injection is supplied in ampoules containing 120 mg of papaverine hydrochloride BP in water for injection. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection DBL Papaverine Hydrochloride Injection is a sterile, clear, colourless to pale-yellow solution. The pH of the injection ranges between 3.0 and 5.0. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS DBL Papaverine Hydrochloride Injection is indicated for the treatment of erectile dysfunction. 4.2 DOSE AND METHOD OF ADMINISTRATION DBL Papaverine Hydrochloride Injection should only be prescribed, and treatment should be supervised, by prescribers having expertise in the management of erectile dysfunction using a range of treatment modalities. The use of DBL Papaverine Hydrochloride Injection in combination with other agents, including phentolamine and alprostadil is not recommended (see section 4.5). DBL Papaverine Hydrochloride Injection should be administered by intracavernosal injection. Before initiation of treatment with DBL Papaverine Hydrochloride Injection, patients should be carefully assessed by a specialist practitioner in erectile dysfunction with appropriate training in the use of this drug. The dose should be titrated carefully according to individual need. The first injection of DBL Papaverine Hydrochloride Injection must be done by medically trained personnel. After proper training and instruction, DBL Papaverine Hydrochloride Injection may be injected at home. If self-administration is planned, the Version: pfdpapai10421 Supercedes : pfdpapai10219 Page 2 of 10 specialist should make an assessment of the patient's (or as appropriate, the partner's) skill and competence with the procedure. While on self-injection treatment, it is recommended that the patient visi Baca dokumen lengkapnya